Resonance Health

OverviewSuggest Edit

Resonance Health is a company that specializes in the development and delivery of non-invasive medical imaging software and services. Its products include FerriScan, Cardiac, bone marrow R2, and more.
TypePublic
Founded1987
HQBurswood, AU
Websiteresonancehealth.com

Latest Updates

Revenue (FY, 2021)$3.8 M(+4%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Resonance Health

Simon Panton

Simon Panton

Non Executive Director
Martin Blake

Martin Blake

Chairman
Mitchell Wells

Mitchell Wells

Non Executive Director
Nick Allan

Nick Allan

Chief Financial Officer and Company Secretary
Show more

Resonance Health Office Locations

Resonance Health has offices in Burswood and Claremont
Burswood, AU (HQ)
141 Burswood Rd
Claremont, AU
278 Stirling Hwy
Show all (2)

Resonance Health Financials and Metrics

Resonance Health Revenue

Resonance Health's revenue was reported to be $3.78 m in FY, 2021
AUD

Revenue (H1, 2022)

1.9m

Gross profit (H1, 2022)

1.9m

Net income (H1, 2022)

(225.0k)

EBITDA (H1, 2022)

(518.0k)

EBIT (H1, 2022)

(726.0k)

Cash (31-Dec-2021)

7.8m
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

2.9m3.6m3.7m3.8m

Gross profit

2.9m3.6m3.9m4.0m

R&D expense

(123.0k)(63.0k)(152.0k)(394.0k)
Half Year
AUDH1, 2019H1, 2020H1, 2021H1, 2022

Revenue

1.8m1.9m770.0k1.9m

Gross profit

1.8m1.9m770.0k1.9m

R&D expense

(55.0k)(111.0k)(290.0k)
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

1.5m3.1m7.0m8.9m

Accounts Receivable

555.0k627.0k740.0k755.0k

Prepaid Expenses

34.0k36.0k40.0k43.0k
Half Year
AUDH1, 2019H1, 2020H1, 2021H1, 2022

Cash

2.1m3.4m8.1m7.8m

Accounts Receivable

795.0k1.1m793.0k1.4m
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

225.0k1.3m(715.0k)586.0k

Depreciation and Amortization

180.0k245.0k284.0k308.0k

Accounts Payable

(236.0k)(50.0k)(44.0k)107.0k
Half Year
AUDH1, 2019H1, 2020H1, 2021H1, 2022

Net Income

934.0k(1.1m)1.1m(225.0k)

Depreciation and Amortization

108.0k168.0k208.0k
Show all financial metrics

Resonance Health Revenue Breakdown

Embed Graph

Resonance Health revenue breakdown by business segment: 100.0% from SERVICES

Resonance Health revenue breakdown by geographic segment: 65.0% from EUROPE-MIDDLE-EAST-AFRICA (EMEA), 30.9% from NORTH AMERICA and 4.2% from Other

Resonance Health Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Resonance Health Online and Social Media Presence

Embed Graph

Resonance Health Blogs

THALASSEMIA INTERNATIONAL FEDERATION TO DEPLOY FERRISMART

Resonance Health Ltd has today signed a Patient Access to FerriSmart® Letter of Agreement with the World Health Organization related Cyprus based Thalassaemia International Federation (TIF).

Introducing LiverSmart: A New AI Medical Device

Resonance Health Ltd announces the development of its newest AI medical device, LiverSmart, which is now undergoing final quality and verification checks prior to its submission to the United States Food & Drug Administration (FDA) for regulatory clearance. LiverSmart combines two existing r…

EASL Digital #NAFLDSummit 2021: Resonance Health presents, HepaFat-AI results equivalent to a conventional MRS technique

Resonance Health attended the EASL Digital NAFLD Summit 2021 on 16 – 17 September and participated with insights into developments in artificial intelligence-based approaches to NAFLD management using HepaFat-AI.

Appointment of GM - Global Sales & Marketing

Resonance Health Ltd (ASX: RHT) (“Resonance Health” or “Company”) advises that Mr. Ajay Nair has been appointed to the new role of General Manager - Global Sales & Marketing.

Resonance Health News - June 2021

Resonance Health is delighted to provide you with our latest customer newsletter, where you can find an update on all our latest acitvities. To read the newsletter please click here

HepaFat-AI Receives CE Marking

Resonance Health Ltd (ASX: RHT) (“Resonance Health” or “Company”) is pleased to announce that it has received CE mark for HepaFat-AI, the Company’s fully automated artificial intelligence (“AI”) software that assesses liver fat (the “Device”).
Show more

Resonance Health Frequently Asked Questions

  • When was Resonance Health founded?

    Resonance Health was founded in 1987.

  • Who are Resonance Health key executives?

    Resonance Health's key executives are Simon Panton, Martin Blake and Mitchell Wells.

  • What is Resonance Health revenue?

    Latest Resonance Health annual revenue is $3.8 m.

  • Who are Resonance Health competitors?

    Competitors of Resonance Health include EBAMed, Perceive3D and SmartScan.

  • Where is Resonance Health headquarters?

    Resonance Health headquarters is located at 141 Burswood Rd, Burswood.

  • Where are Resonance Health offices?

    Resonance Health has offices in Burswood and Claremont.

  • How many offices does Resonance Health have?

    Resonance Health has 2 offices.